Novavax, Inc. (NVAX) and Xcellerex Collaborate on Manufacturing Process for H1N1 Flu Vaccine
Novavax Inc. and Xcellerex Inc. announced today they have entered into a strategic collaboration to accelerate the development of Novavax's…
Blog
Omnicity Corp. (OMCY.OB) Set To Triple Coverage
Omnicity Corp., known for bringing broadband communication service to underserved rural areas, has signed an agreement that will more than…
Pacific Premier Bancorp, Inc. (PPBI) Reports Small Loss in Third Quarter
Pacific Premier Bancorp, Inc. reported a net loss of $7,000, or $0.01 per share, in its third quarter ending 9/30/2009.…
Northwest Biotherapeutics Inc. (NWBO.OB) Helps Cancer Patients with DCVaxA-Brain
Cancer is a deadly killer that has been affecting families globally for far too long. Despite billions of dollars placed…
Clenergen Corp. (CRGE.OB) Reaches Agreement to Terms to Acquire 1.5MW Biomass Power Plant in Tamil Nadu, India
Today it was announced that Clenergen Corporation India Private Limited, a wholly owned subsidiary of Clenergen Corporation, has agreed on…
Inovio Biomedical Corp. (INO) Announces Product Information at Vaccine Conference
Leading DNA vaccine discovery company, Inovio Biomedical Corporation announced that their Scientific Advisory Board Chairman, Dr. David B. Weiner, highlighted…
GVC Venture Corp. (GPAX.OB) Announces Reverse Merger with Financial Holding Company Halo Group Inc.
GVC Venture Corp. made a formal announcement of its recent acquisition of financial services holding company Halo Group Inc. in…
Consorteum Holdings, Inc. (CSRH.OB) Announces Manufacturer and Retailer Solutions for North American and European Markets
Consorteum Holdings Inc. announced today that it has signed a Letter of Intent with Tactical Connections Inc. to provide various…
Oxygen Biotherapeutics, Inc. (OXBO.OB) Announces New Diversified Product Development Plan with Four Strategic Pillars
Oxygen Biotherapeutics now has a clinical development pipeline which includes seven indications for Oxycyte(TM) emulsion. Oxycyte is the Company's perfluorocarbon…
Aethlon Medical, Inc. (AEMD.OB) Up 57.89% Following Yesterday’s Mention in QualityStocks Newsletter
Aethlon Medical Inc. is currently trading at $0.45 a share, up $0.165 or 57.89% for the day. Today's volume has…